Evidence map›Paper›PMID 26932399›Full record

ReviewThe Korean journal of internal medicine2016

The specialist physician's approach to rheumatoid arthritis in South Africa.

Frederik C J Bester, Fredricka J Bosch, Barend J Jansen van Rensburg

Open access · goldAbstract readReview
In one paragraph

Review in The Korean journal of internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Frederik C J BesterDepartment of Internal Medicine, Rosepark Life Health Care Hospital, Bloemfontein, South Africa.
Fredricka J BoschDepartment of Internal Medicine, Rosepark Life Health Care Hospital, Bloemfontein, South Africa.
Barend J Jansen van RensburgDepartment of Internal Medicine, University of Free State Medical School, Bloemfontein, South Africa.
University of the Free State · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is expected to increase in Africa and South Africa. Due to the low numbers of rheumatologists in South Africa, specialist physicians also have to care for patients with RA. Furthermore several new developments have taken place in recent years which improved the management and outcome of RA. Classification criteria were updated, assessment follow-up tools were refined and above all, several new biological disease-modifying anti-rheumatic drugs were developed. Therefore it is imperative for specialist physicians to update themselves with the newest developments in the management of RA. This article provides an overview of the newest developments in the management of RA in the South African context. This approach may well apply to countries with similar specialist to patient ratios and disease profiles.

Indexed as

RheumatologistsSpecializationAntirheumatic AgentsArthritis, RheumatoidDiffusion of InnovationHumansPractice Guidelines as TopicPractice Patterns, Physicians'PrevalenceRisk FactorsSeverity of Illness IndexSouth AfricaTreatment OutcomeAntirheumatic AgentsBiological disease-modifying anti-rheumatic drugRheumatoid arthritis criteriaRheumatoid arthritis managementSouth Africa

Identifiers

PMID26932399
PMCPMC4773728
OpenAlexW2288031878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.